Related references
Note: Only part of the references are listed.The path forward in Alzheimer's disease therapeutics: Reevaluating the amyloid cascade hypothesis
Martin Tolar et al.
ALZHEIMERS & DEMENTIA (2020)
Highly specific detection of Aβ oligomers in early Alzheimer's disease by a near-infrared fluorescent probe with a V-shaped spatial conformation
Jian Yang et al.
CHEMICAL COMMUNICATIONS (2020)
A novel near-infrared fluorescent probe for detection of early-stage Ab protofibrils in Alzheimer's disease
Guanglei Lv et al.
CHEMICAL COMMUNICATIONS (2020)
Oligomers imaging of amyloid-β1-42 by scanning tunneling microscopy
Nobuyasu Naruse et al.
JAPANESE JOURNAL OF APPLIED PHYSICS (2019)
A critical appraisal of amyloid-βtargeting therapies for Alzheimer disease
Francesco Panza et al.
NATURE REVIEWS NEUROLOGY (2019)
The Amyloid-beta Oligomer Hypothesis: Beginning of the Third Decade
Erika N. Cline et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Fluoro-substituted cyanine for reliable in vivo labelling of amyloid-β oligomers and neuroprotection against amyloid-β induced toxicity
Yinhui Li et al.
CHEMICAL SCIENCE (2017)
Tuning the stereo-hindrance of a curcumin scaffold for the selective imaging of the soluble forms of amyloid beta species
Yuyan Li et al.
CHEMICAL SCIENCE (2017)
The amyloid hypothesis of Alzheimer's disease at 25years
Dennis J. Selkoe et al.
EMBO MOLECULAR MEDICINE (2016)
A comparative study of dietary curcumin, nanocurcumin, and other classical amyloid-binding dyes for labeling and imaging of amyloid plaques in brain tissue of 5x-familial Alzheimer's disease mice
Panchanan Maiti et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2016)
The Role of Amyloid-β Oligomers in Toxicity, Propagation, and Immunotherapy
Urmi Sengupta et al.
EBIOMEDICINE (2016)
Chemical Fluorescent Probe for Detection of Aβ Oligomers
Chai Lean Teoh et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
Intracellular amyloid β oligomers impair organelle transport and induce dendritic spine loss in primary neurons
Tomohiro Umeda et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2015)
Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice
Tomohiro Umeda et al.
ACTA NEUROPATHOLOGICA (2014)
The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
Iryna Benilova et al.
NATURE NEUROSCIENCE (2012)
Curcuminoid Binds to Amyloid-β1-42 Oligomer and Fibril
Daijiro Yanagisawa et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Monoclonal Antibody Against the Turn of the 42-Residue Amyloid β-Protein at Positions 22 and 23
Kazuma Murakami et al.
ACS CHEMICAL NEUROSCIENCE (2010)
Relationship between the tautomeric structures of curcumin derivatives and their Aβ-binding activities in the context of therapies for Alzheimer's disease
Daijiro Yanagisawa et al.
BIOMATERIALS (2010)
Convenient method for monitoring Aβ aggregation by quartz-crystal microbalance
Hiroaki Okuno et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2006)
Globular amyloid β-peptide1-42 oligomer -: a homogenous and stable neuropathological protein in Alzheimer's disease
S Barghorn et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Curcumin inhibits formation of amyloid β oligomers and fibrils, binds plaques, and reduces amyloid in vivo
FS Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Curcumin has potent anti-amyloidogenic effects for Alzheimer's β-amyloid fibrils in vitro
K Ono et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2004)
Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo:: evidence for augmentation of a 42-specific γ secretase
JL Jankowsky et al.
HUMAN MOLECULAR GENETICS (2004)
In vitro characterization of conditions for amyloid-β peptide oligomerization and fibrillogenesis
WB Stine et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Share Paper
